Vol. 7 No. 1S (2013)

Published: 2013-07-15

Editorial

The use of nilotinib in clinical practice: monitoring effectiveness and tolerability

Giorgina Specchia

3-7
- HTML
- PDF

Case report

Efficacy and tolerability of treatment with line II nilotinib in a patient with coronary artery disease

Elisa Roncoroni, Maria Luisa Pioltelli, Anna Maria Frustaci, Ester Pungolino, Enrica Morra

9-12
- HTML
- PDF
Complete molecular response induced by nilotinib in a patient previously treated with imatinib, nilotinib and dasatinib

Giuseppe Pietrantuono

13-17
- HTML
- PDF
Deep and early molecular response induced by nilotinb in a newly diagnosed patient with chronic myeloid leukemia (CML)

Antonella Russo Rossi

19-23
- HTML
- PDF
Efficacy of nilotinib in second line in an elderly patient with CML, suboptimal response and multiple comorbidities

Carmen Tomaselli

25-29
- HTML
- PDF